Did you know?

INTRODUCTION. Autoimmune diseases, such as multiple sclerosis (MS), 1, 2 type 1 diabetes (T1D), 3-7 neuromyelitis optica, 8, 9 and lupus erythematosus, 10, 11 involve loss of tolerance to self-antigens in autoreactive B cells, leading to tissue damage, disability, and death. In individuals afflicted by T1D, the insulin-producing beta cells in the pancreas are targeted by an autoimmune ...Cory Berkland. Solon E. Summerfield Distinguished Professor; Department of Pharmaceutical Chemistry; Contact Info. [email protected]. 785-864-1455. Cory Berkland [email protected] Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorCory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;Amir Fakhari1 and Cory Berkland1,2,3,* 1Bioengineering Graduate Program, University of Kansas 2Department of Pharmaceutical Chemistry, School of Pharmacy, ... [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our(31) Hartwell BL, Pickens CJ, Leon M, and Berkland C (2017) Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis, Biomacromolecules 18, 1893–1907. [PMC free article] [Google Scholar]Nanoparticles Targeting Dendritic Cell Surface Molecules Effectively Block T cell Conjugation and Shift Response Chuda Chittasupho1, Laura Shannon2, Teruna J. Siahaan1, Charlotte M. Vines2, and Cory Berkland1,3 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, 66047 2Department of Microbiology, Molecular Genetics and Immunology, University of Kansas MedicalWhat We Do. Our lab works at the interface of medicine and engineering with an emphasis on precisely controlling the physical and chemical properties of particles and biomaterials. The lab environment fosters multidisciplinary interaction between graduate and undergraduate researchers from the departments of Chemical and Petroleum Engineering ... Three decades of promise have culminated in the development of gene therapies that can be applied to a broad range of human diseases. After a brief history, we provide an overview of gene therapy types and delivery methods, gene editing technologies, regulatory affairs, clinical trials, approved pro …Cory Berkland. Solon E. Summerfield Distinguished Professor. Department of Pharmaceutical Chemistry. Contact Info. [email protected]. 785-864-1455. …AU - Berkland, Cory J. N1 - Funding Information: The authors are thankful to the University of Kansas, KS, USA, Washington University, St. Louis, MO, USA, the Deanship of Scientific Research (DSR) at King Abdulaziz University, and the Mohamed Saeed Tamer Chair for Pharmaceutical Industries, King Abdulaziz University, Jeddah, Saudi Arabia for ...C. Berkland et al. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J. Controlled Release (2001) ... Cory Berkland. Functions of the plasminogen receptor Plg‐R KT. Journal of Thrombosis and Haemostasis, Volume 18, Issue 10, 2020, pp. 2468-2481.Cory Berkland, distinguished professor of chemical and petroleum engineering. Lisa Friis, professor of mechanical engineering. Anil Misra, professor of civil, environmental and architectural engineering. Steven Soper, foundation distinguished professor of mechanical enginering and chemistry. Paulette Spencer, distinghuished professor of ...Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berkland C. Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro. Mol Pharm. 2013;11(1):367–73. doi: 10.1021/mp4003909. [PMC free article]Cory BERKLAND | Cited by 10,556 | of University of Kansas, Kansas (KU) | Read 249 publications | Contact Cory BERKLANDCitation: Dormer N, Berkland C, "Single-Step Functional Coatings for Increased Efficiencies". ONdrugDelivery Magazine, Issue 77 (Jul 2017), pp 28-31. In this article about oral drug innovation, Cory Berkland and Nathan Dormer focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of ...LAWRENCE — Cory Berkland might not be the first person you’d guess would help to create what has become a multimillion-dollar company. The distinguished professor, appointed in the departments of Pharmaceutical Chemistry and Chemical & Petroleum Engineering at the University of Kansas, grew up on a pig farm in Iowa, …Dr. Cory Berkland is Chairman of the Board, President, CEO, and Co-Founder of Bond Biosciences. He is Distinguished Professor at The University of Kansas and has extensive experience founding, growing, and exiting pharmaceutical companies including Orbis Biosciences and Savara Pharmaceuticals.Ruolin Lu, 1 Chad Groer, 2 Peter A. Kleindl, 1 K. Ryan Moulder, 1 Aric Huang, 1 Jordan R. Hunt, 1 Shuang Cai, 1, 2 Daniel J. Aires, 2, 3 Cory Berkland, 1 and Laird Forrest 1, 2, * Ruolin Lu 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KansasCory Berkland Co-founder and Chief Executive Officer at Bond Biosciences Solon E. Summerfield Distinguished Professor at The University of Kansas 3yAbdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA

Settimio Pacelli, Sayantani Basu, Cory Berkland, Jinxi Wang and Arghya Paul have no conflicts of interest to disclose. Ethical Approval. This article does not contain any studies with human participants or animals performed by any of the authors. Only commercially obtained cells were used.Berkland Cory [email protected]. Biomaterial(s) Drug delivery system(s) Polymeric biomaterial(s) Polymeric drug delivery system(s) Last Name First Name. Email Address Keywords. Bhambhani Akhilesh [email protected]. Biopharmaceutical characterization. Freeze-drying Gene therapy.864-1455, Fax: (785) 864-1454, [email protected]. ‡Authors contributed equally to this work Supporting Information Figure S1. HSQC NMR data for DEX-N3. Figure S2. Levels of IFN-γ at peak of disease. Figure S3. Levels of IL-6 at peak of disease. Figure S4. Levels of IL-15 at peak of disease. Figure S5. Levels of IL-17A at peak of disease ...Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA

Prof. Cory Berkland (Chair) Prof. Marylee Southard Prof. Stevin Gehrke Date Approved: iii Abstract: Magnetic nanoparticles that display high saturation magnetization and high magnetic susceptibility with a size less than 200 nm are of great interest for medical applications. Investigations of magnetic nanoparticles have beenCory Berkland Songyot Anuchapreeda: Keywords: Agricultural and Biological Sciences;Biochemistry, Genetics and Molecular Biology;Chemistry: Issue Date: 1-Jan-2021: Abstract: The magnolia plant has been used in traditional medicine since ancient times. This study was designed to investigate the effects of active compounds from Thai Champi ...…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Settimio Pacelli, a, 1 Sayantani Basu, a, 1 Jonat. Possible cause: Aug 5, 2020 · Cory Berkland is a professor of pharmaceutical chemistry a.